Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer

David McConkey, Woonyoung Choi, Andrea Ochoa, Arlene Siefker-Radtke, Bogdan Czerniak, Colin P.N. Dinney

Research output: Contribution to journalReview article

Abstract

Recent studies revealed that muscle-invasive bladder cancers segregate into intrinsic basal and luminal subtypes that are similar to those described for breast cancer. Each subtype is enriched with potentially clinically actionable genomic alterations and epigenetic signatures; there are associations between tumor subtype and sensitivity to conventional cisplatin-based chemotherapy. The authors review biological and clinical characteristics of the intrinsic subtypes and describe their implications for the development of conventional and targeted agents. The role that tumor plasticity seems to play in basal and luminal bladder cancer biology and its potential effects on the development of therapeutic resistance is also discussed.

Original languageEnglish (US)
JournalHematology/Oncology Clinics of North America
Volume29
Issue number2
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Muscles
Epigenomics
Cisplatin
Neoplasms
Breast Neoplasms
Drug Therapy
Therapeutics

Keywords

  • Basal and luminal
  • Neoadjuvant chemotherapy
  • Urothelial cancer

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer. / McConkey, David; Choi, Woonyoung; Ochoa, Andrea; Siefker-Radtke, Arlene; Czerniak, Bogdan; Dinney, Colin P.N.

In: Hematology/Oncology Clinics of North America, Vol. 29, No. 2, 01.04.2015.

Research output: Contribution to journalReview article

McConkey, David ; Choi, Woonyoung ; Ochoa, Andrea ; Siefker-Radtke, Arlene ; Czerniak, Bogdan ; Dinney, Colin P.N. / Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer. In: Hematology/Oncology Clinics of North America. 2015 ; Vol. 29, No. 2.
@article{f54e5e78031c45a6b9296ca2200ca7ec,
title = "Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer",
abstract = "Recent studies revealed that muscle-invasive bladder cancers segregate into intrinsic basal and luminal subtypes that are similar to those described for breast cancer. Each subtype is enriched with potentially clinically actionable genomic alterations and epigenetic signatures; there are associations between tumor subtype and sensitivity to conventional cisplatin-based chemotherapy. The authors review biological and clinical characteristics of the intrinsic subtypes and describe their implications for the development of conventional and targeted agents. The role that tumor plasticity seems to play in basal and luminal bladder cancer biology and its potential effects on the development of therapeutic resistance is also discussed.",
keywords = "Basal and luminal, Neoadjuvant chemotherapy, Urothelial cancer",
author = "David McConkey and Woonyoung Choi and Andrea Ochoa and Arlene Siefker-Radtke and Bogdan Czerniak and Dinney, {Colin P.N.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.hoc.2014.11.003",
language = "English (US)",
volume = "29",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer

AU - McConkey, David

AU - Choi, Woonyoung

AU - Ochoa, Andrea

AU - Siefker-Radtke, Arlene

AU - Czerniak, Bogdan

AU - Dinney, Colin P.N.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Recent studies revealed that muscle-invasive bladder cancers segregate into intrinsic basal and luminal subtypes that are similar to those described for breast cancer. Each subtype is enriched with potentially clinically actionable genomic alterations and epigenetic signatures; there are associations between tumor subtype and sensitivity to conventional cisplatin-based chemotherapy. The authors review biological and clinical characteristics of the intrinsic subtypes and describe their implications for the development of conventional and targeted agents. The role that tumor plasticity seems to play in basal and luminal bladder cancer biology and its potential effects on the development of therapeutic resistance is also discussed.

AB - Recent studies revealed that muscle-invasive bladder cancers segregate into intrinsic basal and luminal subtypes that are similar to those described for breast cancer. Each subtype is enriched with potentially clinically actionable genomic alterations and epigenetic signatures; there are associations between tumor subtype and sensitivity to conventional cisplatin-based chemotherapy. The authors review biological and clinical characteristics of the intrinsic subtypes and describe their implications for the development of conventional and targeted agents. The role that tumor plasticity seems to play in basal and luminal bladder cancer biology and its potential effects on the development of therapeutic resistance is also discussed.

KW - Basal and luminal

KW - Neoadjuvant chemotherapy

KW - Urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=84989790803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989790803&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2014.11.003

DO - 10.1016/j.hoc.2014.11.003

M3 - Review article

C2 - 25836941

AN - SCOPUS:84933523844

VL - 29

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 2

ER -